120 related articles for article (PubMed ID: 2004349)
1. Carcinogenicity study of fecapentaene-12 diacetate on skin painting in SENCAR mice.
Devor DE; Henneman JR; Keefer LK; Logsdon DL; Rice JM; Streeter AJ; Ward JM
Cancer Lett; 1991 Jan; 56(1):11-5. PubMed ID: 2004349
[TBL] [Abstract][Full Text] [Related]
2. Inactivity of fecapentaene-12 as a rodent carcinogen or tumor initiator.
Ward JM; Anjo T; Ohannesian L; Keefer LK; Devor DE; Donovan PJ; Smith GT; Henneman JR; Streeter AJ; Konishi N
Cancer Lett; 1988; 42(1-2):49-59. PubMed ID: 3141039
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E is a complete tumor promoter in mouse skin.
Mitchel RE; McCann R
Carcinogenesis; 1993 Apr; 14(4):659-62. PubMed ID: 8472330
[TBL] [Abstract][Full Text] [Related]
4. Promoter independence as a feature of most skin papillomas in SENCAR mice.
Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J
Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
Ewing MW; Crysup SE; Phillips JL; Slaga TJ; DiGiovanni J
Carcinogenesis; 1988 Mar; 9(3):405-10. PubMed ID: 3125993
[TBL] [Abstract][Full Text] [Related]
6. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the tumorigenic response of SENCAR and C57BL/6 mice to benzo(a)pyrene and the inter-experimental variability over a three-year period.
Nesnow S; Bergman H; Slaga TJ
Environ Health Perspect; 1986 Sep; 68():19-25. PubMed ID: 3780628
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of dietary beta-carotene on papilloma and carcinoma formation induced by an initiation-promotion protocol in SENCAR mouse skin.
Chen LC; Sly L; Jones CS; Tarone R; De Luca LM
Carcinogenesis; 1993 Apr; 14(4):713-7. PubMed ID: 8472337
[TBL] [Abstract][Full Text] [Related]
9. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
10. Effects of short-term exposure to the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate on skin carcinogenesis in SENCAR mice.
Diwan BA; Ward JM; Henneman J; Wenk ML
Cancer Lett; 1985 Mar; 26(2):177-84. PubMed ID: 3919937
[TBL] [Abstract][Full Text] [Related]
11. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
[TBL] [Abstract][Full Text] [Related]
12. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia and phorbol ester tumor promotion in mouse skin.
Mitchel RE; Morrison DP; Gragtmans NJ; Jevcak JJ
Carcinogenesis; 1986 Sep; 7(9):1505-10. PubMed ID: 3091284
[TBL] [Abstract][Full Text] [Related]
14. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
[TBL] [Abstract][Full Text] [Related]
15. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
Kruszewski FH; Conti CJ; DiGiovanni J
Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
[TBL] [Abstract][Full Text] [Related]
16. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
[TBL] [Abstract][Full Text] [Related]
17. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
DiGiovanni J; Walker SE; Aldaz CM; Slaga TJ; Conti CJ
Carcinogenesis; 1993 Sep; 14(9):1831-6. PubMed ID: 8403206
[TBL] [Abstract][Full Text] [Related]
18. Influences of sphingosine on two-stage skin tumorigenesis in Sencar mice.
Enkvetchakul B; Barnett T; Liotta DC; Geisler V; Menaldino D; Merrill AH; Birt DF
Cancer Lett; 1992 Feb; 62(1):35-42. PubMed ID: 1540929
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the inhibitory effects of retinoids on 12-O-tetradecanoylphorbol-13-acetate-promoted tumor formation in CD-1 and Sencar mice.
Dawson MI; Chao WR
Cancer Lett; 1988 May; 40(1):7-12. PubMed ID: 3130981
[TBL] [Abstract][Full Text] [Related]
20. Acceleration of papilloma growth in mice fed high-fat diets during promotion of two-stage skin carcinogenesis.
Birt DF; Pelling JC; Tibbels MG; Schweickert L
Nutr Cancer; 1989; 12(2):161-8. PubMed ID: 2496398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]